• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全球流感疫苗使用的新出发点

New Points of Departure for More Global Influenza Vaccine Use.

作者信息

Kiseleva Irina

机构信息

Department of Virology, Federal State Budgetary ScYientific Institution, Institute of Experimental Medicine, 197376 St Petersburg, Russia.

Faculty of Dental Medicine and Medical Technologies, St Petersburg University, 199034 St Petersburg, Russia.

出版信息

Vaccines (Basel). 2020 Jul 23;8(3):410. doi: 10.3390/vaccines8030410.

DOI:10.3390/vaccines8030410
PMID:32718042
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7563509/
Abstract

Each year, influenza causes a significant acute respiratory disease burden. In addition, influenza pandemics periodically occur. Annual vaccination is the best tool for influenza prevention, but its effectiveness can vary from year to year. The narrow specificity of conventional vaccines and the drug resistance of currently circulating viruses reduce the effectiveness of prophylaxis and treatment and require the development of new broad-spectrum preparations. Furthermore, the challenge of creating a highly effective universal influenza vaccine takes on renewed intensity in the face of the COVID-19 pandemic.

摘要

每年,流感都会造成严重的急性呼吸道疾病负担。此外,流感大流行定期发生。年度疫苗接种是预防流感的最佳工具,但其效果每年可能会有所不同。传统疫苗的特异性狭窄以及当前流行病毒的耐药性降低了预防和治疗的效果,需要开发新的广谱制剂。此外,面对新冠疫情,研发高效通用流感疫苗的挑战再度加剧。

相似文献

1
New Points of Departure for More Global Influenza Vaccine Use.全球流感疫苗使用的新出发点
Vaccines (Basel). 2020 Jul 23;8(3):410. doi: 10.3390/vaccines8030410.
2
A Live-Attenuated Prime, Inactivated Boost Vaccination Strategy with Chimeric Hemagglutinin-Based Universal Influenza Virus Vaccines Provides Protection in Ferrets: A Confirmatory Study.基于嵌合血凝素的通用流感病毒疫苗的减毒活疫苗初免-灭活疫苗加强免疫接种策略在雪貂中提供保护:一项验证性研究。
Vaccines (Basel). 2018 Jul 25;6(3):47. doi: 10.3390/vaccines6030047.
3
Vaccines for seasonal and pandemic influenza.季节性流感和大流行性流感疫苗。
J Infect Dis. 2006 Nov 1;194 Suppl 2:S111-8. doi: 10.1086/507544.
4
Seasonal influenza vaccines.季节性流感疫苗
Curr Top Microbiol Immunol. 2009;333:43-82. doi: 10.1007/978-3-540-92165-3_3.
5
Development and approval of live attenuated influenza vaccines based on Russian master donor viruses: Process challenges and success stories.基于俄罗斯主供体病毒的减毒活流感疫苗的研发与获批:过程挑战与成功案例
Vaccine. 2016 Oct 26;34(45):5436-5441. doi: 10.1016/j.vaccine.2016.08.018. Epub 2016 Sep 1.
6
Overview of Influenza Vaccines in Children.儿童流感疫苗概述
J Pediatric Infect Dis Soc. 2013 Dec;2(4):368-78. doi: 10.1093/jpids/pit053. Epub 2013 Sep 24.
7
Influenza.流感
Infect Dis Clin North Am. 2000 Mar;14(1):141-66. doi: 10.1016/s0891-5520(05)70222-1.
8
Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge.接种表达神经氨酸酶的重组副流感病毒5可抵御同源和异源流感病毒攻击。
J Virol. 2017 Nov 14;91(23). doi: 10.1128/JVI.01579-17. Print 2017 Dec 1.
9
Comparison of Adjuvanted-Whole Inactivated Virus and Live-Attenuated Virus Vaccines against Challenge with Contemporary, Antigenically Distinct H3N2 Influenza A Viruses.佐剂全灭活病毒与减毒活病毒疫苗对当代抗原性不同的 H3N2 流感 A 病毒挑战的比较。
J Virol. 2018 Oct 29;92(22). doi: 10.1128/JVI.01323-18. Print 2018 Nov 15.
10
Alternative Strategy for a Quadrivalent Live Attenuated Influenza Virus Vaccine.四价活流感病毒疫苗的替代策略。
J Virol. 2018 Oct 12;92(21). doi: 10.1128/JVI.01025-18. Print 2018 Nov 1.

引用本文的文献

1
Harnessing the non-specific immunogenic effects of available vaccines to combat COVID-19.利用现有疫苗的非特异性免疫原性效应来对抗 COVID-19。
Hum Vaccin Immunother. 2021 Jun 3;17(6):1650-1661. doi: 10.1080/21645515.2020.1833577. Epub 2020 Nov 13.
2
Efforts to Improve the Seasonal Influenza Vaccine.改善季节性流感疫苗的努力。
Vaccines (Basel). 2020 Nov 3;8(4):645. doi: 10.3390/vaccines8040645.
3
Impact of the COVID-19 Pandemic on Routine Childhood Immunization in Saudi Arabia.新冠疫情对沙特阿拉伯儿童常规免疫接种的影响

本文引用的文献

1
Prospects and Challenges in the Development of Universal Influenza Vaccines.通用流感疫苗研发中的前景与挑战
Vaccines (Basel). 2020 Jul 6;8(3):361. doi: 10.3390/vaccines8030361.
2
Are coinfections with COVID-19 and influenza low or underreported? An observational study examining current published literature including three new unpublished cases.新冠病毒和流感的合并感染是否较低或报告不足?一项观察性研究检查了当前已发表的文献,包括三例新的未发表病例。
J Med Virol. 2020 Nov;92(11):2489-2497. doi: 10.1002/jmv.26167. Epub 2020 Jun 29.
3
Influenza and COVID-19 coinfection: Report of six cases and review of the literature.
Vaccines (Basel). 2020 Oct 3;8(4):581. doi: 10.3390/vaccines8040581.
流感和 COVID-19 合并感染:六例病例报告及文献复习。
J Med Virol. 2020 Nov;92(11):2657-2665. doi: 10.1002/jmv.26125. Epub 2020 Jun 29.
4
The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system.COVID-19 中的细胞因子风暴:趋化因子/趋化因子受体系统的参与概述。
Cytokine Growth Factor Rev. 2020 Jun;53:25-32. doi: 10.1016/j.cytogfr.2020.05.003. Epub 2020 May 11.
5
Rational Vaccine Design in the Time of COVID-19.新冠疫情时期的合理疫苗设计。
Cell Host Microbe. 2020 May 13;27(5):695-698. doi: 10.1016/j.chom.2020.04.022.
6
Rapid COVID-19 vaccine development.新冠疫苗的快速研发。
Science. 2020 May 29;368(6494):945-946. doi: 10.1126/science.abb8923. Epub 2020 May 8.
7
The possible beneficial adjuvant effect of influenza vaccine to minimize the severity of COVID-19.流感疫苗可能具有的有益辅助作用,可将新冠病毒疾病(COVID-19)的严重程度降至最低。
Med Hypotheses. 2020 Apr 22;140:109752. doi: 10.1016/j.mehy.2020.109752.
8
Is BCG vaccination affecting the spread and severity of COVID-19?卡介苗接种会影响新冠病毒疾病(COVID-19)的传播和严重程度吗?
Allergy. 2020 Jul;75(7):1824-1827. doi: 10.1111/all.14344. Epub 2020 May 12.
9
Seasonal and pandemic influenza: 100 years of progress, still much to learn.季节性流感和大流行性流感:百年进展,仍有许多未知。
Mucosal Immunol. 2020 Jul;13(4):566-573. doi: 10.1038/s41385-020-0287-5. Epub 2020 Apr 21.
10
Human Challenge Studies to Accelerate Coronavirus Vaccine Licensure.人类挑战研究加速冠状病毒疫苗许可。
J Infect Dis. 2020 May 11;221(11):1752-1756. doi: 10.1093/infdis/jiaa152.